Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$7,457,603
+$1,006,415 QoQ
Shares Held
29,636
-0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#1,069
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 41%
Shared 0%
None 59%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWLAND CAPITAL MANAGEMENT LLC holds $45,192,590 across 9 Drug Manufacturers - General names. ABBV ranks #2 (16.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,734 | $22,281,803 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
29,636 | $7,457,603 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,824 | $5,888,384 | |
| 4 | LLY |
ELI LILLY & Co
|
3,121 | $3,743,421 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
11,420 | $1,442,802 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
22,408 | $1,291,148 | |
| 7 | AMGN |
Amgen Inc
|
3,560 | $1,289,147 | |
| 8 | PFE |
Pfizer Inc
|
51,607 | $1,242,696 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,457,603 | 29,636 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $6,451,188 | 29,662 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $6,936,042 | 30,356 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,663,026 | 28,777 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $5,288,499 | 28,491 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $5,971,948 | 28,503 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,189,988 | 23,579 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $4,637,620 | 23,484 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,075,143 | 23,759 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $4,549,040 | 24,981 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $4,027,050 | 25,986 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $3,899,707 | 26,162 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $3,615,749 | 26,837 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $4,285,299 | 26,889 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $4,222,546 | 26,128 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $3,295,258 | 24,553 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $3,422,819 | 22,348 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $2,871,454 | 17,713 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,355,960 | 17,400 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $1,871,544 | 17,350 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $1,971,763 | 17,505 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $1,882,054 | 17,391 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $1,887,018 | 17,611 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $1,553,233 | 17,733 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,754,280 | 17,868 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $1,422,086 | 18,665 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||